• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.基于鞅残差的两种形式检验在灵活参数超额风险模型中用于检验比例风险假设和预后因素函数形式的性能。
Biostatistics. 2017 Jul 1;18(3):505-520. doi: 10.1093/biostatistics/kxw056.
2
Estimation of covariate effects on net survivals in the relative survival progressive illness-death model.在相对生存渐进式疾病-死亡模型中,对协变量对净生存的影响的估计。
Stat Methods Med Res. 2021 Jun;30(6):1538-1553. doi: 10.1177/09622802211003608. Epub 2021 May 8.
3
Dynamic regression hazards models for relative survival.相对生存的动态回归风险模型。
Stat Med. 2008 Aug 15;27(18):3563-84. doi: 10.1002/sim.3242.
4
Estimating excess hazard ratios and net survival when covariate data are missing: strategies for multiple imputation.协变量数据缺失时估计超额风险比和净生存率:多重填补策略
Epidemiology. 2015 May;26(3):421-8. doi: 10.1097/EDE.0000000000000283.
5
Estimating net survival: the importance of allowing for informative censoring.估计净生存率:允许信息性删失的重要性。
Stat Med. 2012 Apr 13;31(8):775-86. doi: 10.1002/sim.4464. Epub 2012 Jan 26.
6
Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.阿alen加法模型与Cox比例风险模型对乳腺癌生存率的比较:基于加拿大不列颠哥伦比亚省人群数据的分析
Asian Pac J Cancer Prev. 2011;12(11):3113-6.
7
Individual frailty excess hazard models in cancer epidemiology.癌症流行病学中的个体脆弱性超额风险模型。
Stat Med. 2023 Mar 30;42(7):1066-1081. doi: 10.1002/sim.9657. Epub 2023 Jan 24.
8
An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.评估Cox模型比例风险假设的统计检验的实证比较。
Stat Med. 1997 Mar 30;16(6):611-26. doi: 10.1002/(sici)1097-0258(19970330)16:6<611::aid-sim437>3.0.co;2-t.
9
A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates.一种用于估计分层数据净生存的多水平超额风险模型,该模型允许协变量具有非线性和非比例效应。
Stat Med. 2016 Aug 15;35(18):3066-84. doi: 10.1002/sim.6881. Epub 2016 Feb 28.
10
A permutation test based on the restricted mean survival time for comparison of net survival distributions in non-proportional excess hazard settings.基于受限平均生存时间的排列检验,用于比较非比例超风险环境下的净生存分布。
Stat Methods Med Res. 2020 Jun;29(6):1612-1623. doi: 10.1177/0962280219870217. Epub 2019 Aug 28.

引用本文的文献

1
Addition of [ F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross-Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma.正电子发射断层扫描与计算机断层扫描联合应用于 [F]氟脱氧葡萄糖改善肝细胞癌的分期并改变其治疗策略。
Liver Transpl. 2020 Jun;26(6):774-784. doi: 10.1002/lt.25743. Epub 2020 May 8.
2
Dietary protein intake and all-cause and cause-specific mortality: results from the Rotterdam Study and a meta-analysis of prospective cohort studies.饮食蛋白质摄入量与全因死亡率和死因特异性死亡率:来自鹿特丹研究和前瞻性队列研究荟萃分析的结果。
Eur J Epidemiol. 2020 May;35(5):411-429. doi: 10.1007/s10654-020-00607-6. Epub 2020 Feb 19.

本文引用的文献

1
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).滤泡性淋巴瘤或弥漫性大B细胞淋巴瘤诊断后超额死亡率和净生存率的动态变化:基于欧洲人群数据(EUROCARE-5)的比较
Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23.
2
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.2000 - 2007年欧洲淋巴和髓系恶性肿瘤按国家和年龄划分的生存差异:基于人群的EUROCARE - 5研究结果
Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26.
3
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
4
A general framework for parametric survival analysis.参数生存分析的一般框架。
Stat Med. 2014 Dec 30;33(30):5280-97. doi: 10.1002/sim.6300. Epub 2014 Sep 15.
5
Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.基于净生存无偏估计的法国癌症患者癌症和其他原因死亡概率:五种常见癌症的研究。
Cancer Epidemiol. 2013 Dec;37(6):857-63. doi: 10.1016/j.canep.2013.08.006. Epub 2013 Sep 22.
6
Estimating the loss in expectation of life due to cancer using flexible parametric survival models.使用灵活的参数生存模型估计癌症导致的预期寿命损失。
Stat Med. 2013 Dec 30;32(30):5286-300. doi: 10.1002/sim.5943. Epub 2013 Aug 23.
7
Use of relative and absolute effect measures in reporting health inequalities: structured review.报告健康不平等状况时使用相对和绝对效果测量指标:系统综述。
BMJ. 2012 Sep 3;345:e5774. doi: 10.1136/bmj.e5774.
8
Estimating net survival: the importance of allowing for informative censoring.估计净生存率:允许信息性删失的重要性。
Stat Med. 2012 Apr 13;31(8):775-86. doi: 10.1002/sim.4464. Epub 2012 Jan 26.
9
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study.1990-2007 年慢性期慢性髓性白血病超额死亡率动态变化:一项人群研究。
Blood. 2011 Oct 20;118(16):4331-7. doi: 10.1182/blood-2011-01-330332. Epub 2011 Aug 17.
10
On estimation in relative survival.关于相对生存的估计
Biometrics. 2012 Mar;68(1):113-20. doi: 10.1111/j.1541-0420.2011.01640.x. Epub 2011 Jun 20.

基于鞅残差的两种形式检验在灵活参数超额风险模型中用于检验比例风险假设和预后因素函数形式的性能。

Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.

作者信息

Danieli Coraline, Bossard Nadine, Roche Laurent, Belot Aurelien, Uhry Zoe, Charvat Hadrien, Remontet Laurent

机构信息

Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, F-69003, Lyon, France, and CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Université Lyon 1, F-69100, Villeurbanne, France and McGill University Health Center, Department of Epidemiology, Biostatistics and Occupational Health, H3A 1A2, Montreal, QC, Canada.

Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, F-69003, Lyon, France and CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Université Lyon 1, F-69100, Villeurbanne, France.

出版信息

Biostatistics. 2017 Jul 1;18(3):505-520. doi: 10.1093/biostatistics/kxw056.

DOI:10.1093/biostatistics/kxw056
PMID:28334368
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6166776/
Abstract

Net survival, the one that would be observed if the disease under study was the only cause of death, is an important, useful, and increasingly used indicator in public health, especially in population-based studies. Estimates of net survival and effects of prognostic factor can be obtained by excess hazard regression modeling. Whereas various diagnostic tools were developed for overall survival analysis, few methods are available to check the assumptions of excess hazard models. We propose here two formal tests to check the proportional hazard assumption and the validity of the functional form of the covariate effects in the context of flexible parametric excess hazard modeling. These tests were adapted from martingale residual-based tests for parametric modeling of overall survival to allow adding to the model a necessary element for net survival analysis: the population mortality hazard. We studied the size and the power of these tests through an extensive simulation study based on complex but realistic data. The new tests showed sizes close to the nominal values and satisfactory powers. The power of the proportionality test was similar or greater than that of other tests already available in the field of net survival. We illustrate the use of these tests with real data from French cancer registries.

摘要

净生存率是指如果所研究的疾病是唯一的死亡原因时所观察到的生存率,它是公共卫生领域中一项重要、有用且使用越来越频繁的指标,尤其是在基于人群的研究中。净生存率的估计以及预后因素的效应可以通过超额风险回归模型获得。虽然已经开发了各种用于总体生存分析的诊断工具,但用于检验超额风险模型假设的方法却很少。在此,我们提出两种形式化检验,以在灵活的参数化超额风险建模背景下检验比例风险假设和协变量效应函数形式的有效性。这些检验是从基于鞅残差的总体生存参数化建模检验改编而来,以便在模型中加入净生存分析所需的一个要素:人群死亡风险。我们通过基于复杂但现实的数据进行的广泛模拟研究,研究了这些检验的大小和功效。新检验显示其大小接近名义值且功效令人满意。比例性检验的功效与净生存领域中已有的其他检验相似或更高。我们用来自法国癌症登记处的真实数据说明了这些检验的用途。